TT INTERNATIONAL - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2020. The put-call ratio across all filers is 0.11 and the average weighting 1.3%.

Quarter-by-quarter ownership
TT INTERNATIONAL ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q3 2020$275,000
-88.4%
2,479
-90.4%
0.01%
-94.4%
Q1 2019$2,368,000
-2.4%
25,953
-18.8%
0.25%
-19.9%
Q4 2018$2,425,000
+21.2%
31,953
+27.8%
0.31%
+39.9%
Q3 2018$2,000,00025,0000.22%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q3 2020
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 137,557$11,142,0006.62%
COMGEST GLOBAL INVESTORS S.A.S. 637,752$51,658,0001.13%
Black Creek Investment Management Inc. 411,525$33,334,0001.09%
Hillhouse Capital Management 618,391$50,090,0000.88%
RUDMAN ERROL M 21,301$1,725,0000.83%
JUPITER ASSET MANAGEMENT LTD 263,705$21,360,0000.65%
York Capital Management Global Advisors, LLC 341,616$27,671,0000.62%
VONTOBEL ASSET MANAGEMENT INC 873,968$71,525,0000.51%
Temasek Holdings (Private) Ltd 990,000$80,190,0000.44%
WASATCH ADVISORS LP 292,216$23,669,0000.31%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders